ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Edesa Biotech to continue global Covid-19 drug trial pharmaceutical-technology
June 22, 2021Edesa Biotech is set to continue Phase II/III clinical study of its drug candidate, EB05, to treat patients hospitalised with Covid-19 on receiving an independent Data and Safety Monitoring Board’s (DSMB) recommendation. -
Edesa Biotech gets FDA approval for EB05 trial to treat Covid-19 pharmaceutical-technology
October 22, 2020Biopharma firm Edesa Biotech has received clearance from the US Food and Drug Administration (FDA) to initiate the Phase II part of Phase II / III clinical trial of its investigational drug EB05 to treat hospitalised patients with Covid-19.
Pharma Sources Insight January 2025
